Association between COPD assessment test (CAT) and disease severity based on reduction of respiratory volumes in chemical warfare victims

Tanaffos

Volumn 10, Issue 4, 2011, Pages 38-42

  Fadaii, Abbas ^a   Sohrabpour, Hamid ^a   Taherkhanchi, Bahar ^a   Bagheri, Bahador ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chemical warfare victim; COPD; COPD assessment test (CAT); Respiratory status; Spirometry

Indexed keywords

ADULT; AGED; ARTICLE; CHEMICAL WARFARE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; COPD ASSESSMENT TEST; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH SURVEY; HUMAN; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; SCORING SYSTEM; SPIROMETRY;

EID: 84855609579     PISSN: 17350344     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997; 52 Suppl 5: S1-S28.
2. Mahler DA, Tomlinson D, Olmstead EM, Tosteson AN, O'Connor GT. Changes in dyspnea, health status, and lung function in chronic airway disease. Am J Respir Crit Care Med 1995; 151 (1): 61-65.
3. van den Berge M, ten Hacken NH, Cohen J, Douma WR, Postma DS. Small airway disease in asthma and COPD: clinical implications. Chest 2011; 139 (2): 412-423.
4. Ghanei M, Adibi I, Farhat F, Aslani J. Late respiratory effects of sulfur mustard: how is the early symptoms severity involved? Chron Respir Dis 2008; 5 (2): 95-100.
5. Bagheri MH, Hosseini SK, Mostafavi SH, Alavi SA. High-resolution CT in chronic pulmonary changes after mustard gas exposure. Acta Radiol 2003; 44 (3): 241-245.
6. Ghanei M, Hosseini AR, Arabbaferani Z, Shahkarami E. Evaluation of chronic cough in chemical chronic bronchitis patients. Environ Toxicol Pharmacol 2005; 20 (1): 6-10.
7. Emad A, Rezaian GR. The diversity of the effects of sulfur mustard gas inhalation on respiratory system 10 years after a single, heavy exposure: analysis of 197 cases. Chest 1997; 112: 734-8.
8. Engström CP, Persson LO, Larsson S, Sullivan M. Health-related quality of life in COPD: why both disease-specific and generic measures should be used. Eur Respir J 2001; 18 (1): 69-76.
9. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J 2009; 34 (3): 648-654.
10. Jones P, Harding G, Wiklund I, Berry P, Leidy N. Improving the process and outcome of care in COPD: development of a standardised assessment tool. Prim Care Respir J 2009; 18 (3): 208-215.
11. Gupta B, Kant S. Health Related Quality Of Life (Hrqol) In COPD. The Internet Journal of Pulmonary Medicine 2009, 11(1).
12. Jones PW. Quality of life measurement for patients with diseases of the airways. Thorax 1991; 46 (9): 676-682.
13. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991; 85 Suppl B: 25-31; discussion 33-37.
14. Belman MJ, Botnick WC, Shin JW. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153 (3): 967-975.
15. Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax 2001; 56 (11): 880-887.
16. Jones PW, Baveystock CM, Littlejohns P. Relationships between general health measured with the sickness impact profile and respiratory symptoms, physiological measures, and mood in patients with chronic airflow limitation. Am Rev Respir Dis 1989; 140 (6): 1538-1543.